多囊卵巢综合征的药物治疗进展

Drug treatment progression of polycystic ovary syndrome

关键词:  多囊卵巢综合征（PCOS）是一种最常见的妇科内分泌疾病，为持续无排卵或排卵过少，临床或实验室检查，常伴雄激素过多症、胰岛素抵抗等内分泌异常。起病多见于青春期。PCOS的病因尚未明确，目前药物治疗以针对肥胖、高雄激素血症、胰岛素抵抗及不孕方面的药物为主。本文就近年来对PCOS的药物治疗进展进行综述。

Key words:  polycystic ovary syndrome  endocrine abnormalities  medical therapy

摘要:

多囊卵巢综合征（PCOS）是一种最常见的妇科内分泌疾病，为持续无排卵或排卵过少，临床或实验室检查，常伴雄激素过多症、胰岛素抵抗等内分泌异常。起病多见于青春期。PCOS的病因尚未明确，目前药物治疗以针对肥胖、高雄激素血症、胰岛素抵抗及不孕方面的药物为主。本文就近年来对PCOS的药物治疗进展进行综述。

Abstract:

Polycystic ovary syndrome (PCOS) is one of the most common gynecologic endocrine diseases. It has been defined as chronic anovulation or oligoovulation with clinical or laboratory evidence of hyperandrogenism，and is often accompanied by endocrine abnormalities such as insulin resistance. Its onset generally occurs at the time of puberty. The cause of PCOS is unclear. At present, the drug treatment mainly aims at obesity，hyperandrogenism，insulin resistance and infertility. Drug treatment progression of polycystic ovary syndrome is reviewed in this paper.